?>
Plan Name | LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN |
Plan identification number | 001 |
401k Plan Type | Defined Benefit Pension |
Plan Features/Benefits |
|
Company Name: | LEIDOS BIOMEDICAL RESEARCH, INC. |
Employer identification number (EIN): | 330653185 |
NAIC Classification: | 541700 |
Additional information about LEIDOS BIOMEDICAL RESEARCH, INC.
Jurisdiction of Incorporation: | Virginia Secretary of State |
Incorporation Date: | 2003-01-15 |
Company Identification Number: | F153610 |
Legal Registered Office Address: |
4701 Cox Rd Ste 285 Glen Allen United States of America (USA) 23060-6808 |
More information about LEIDOS BIOMEDICAL RESEARCH, INC.
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
001 | 2022-01-01 | ||||
001 | 2021-01-01 | ||||
001 | 2020-01-01 | ||||
001 | 2019-01-01 | ||||
001 | 2018-01-01 | ||||
001 | 2017-01-01 | DAVID M FRICK | TIMOTHY BOYLE | 2018-10-04 | |
001 | 2016-01-01 | DAVID M FRICK | TIMOTHY BOYLE | 2017-10-10 | |
001 | 2015-01-01 | DAVID M FRICK | TIMOTHY BOYLE | 2016-10-14 | |
001 | 2014-01-01 | DAVID M FRICK | TIMOTHY BOYLE | 2015-10-14 | |
001 | 2013-01-01 | KENNETH R. CARPENTER, JR. | KENNETH R. CARPENTER, JR. | 2014-10-14 | |
001 | 2012-01-01 | KENNETH R. CARPENTER, JR. | KENNETH R. CARPENTER, JR. | 2013-10-07 | |
001 | 2011-01-01 | KENNETH R. CARPENTER, JR. | KENNETH R. CARPENTER, JR. | 2012-10-03 | |
001 | 2009-01-01 | REBECCA NEWHALL | REBECCA NEWHALL | 2010-10-14 |
Measure | Date | Value |
---|---|---|
2022: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2022 401k membership | ||
Market value of plan assets | 2022-12-31 | 300,720,848 |
Acturial value of plan assets | 2022-12-31 | 288,114,344 |
Funding target for retired participants and beneficiaries receiving payment | 2022-12-31 | 121,226,017 |
Number of terminated vested participants | 2022-12-31 | 444 |
Fundng target for terminated vested participants | 2022-12-31 | 29,600,197 |
Active participant vested funding target | 2022-12-31 | 73,967,392 |
Number of active participants | 2022-12-31 | 540 |
Total funding liabilities for active participants | 2022-12-31 | 74,314,084 |
Total participant count | 2022-12-31 | 1,716 |
Total funding target for all participants | 2022-12-31 | 225,140,298 |
Balance at beginning of prior year after applicable adjustments | 2022-12-31 | 0 |
Prefunding balance at beginning of prior year after applicable adjustments | 2022-12-31 | 3,746 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2022-12-31 | 0 |
Prefunding balanced used to offset prior years funding requirement | 2022-12-31 | 0 |
Amount remaining of carryover balance | 2022-12-31 | 0 |
Amount remaining of prefunding balance | 2022-12-31 | 3,746 |
Present value of excess contributions | 2022-12-31 | 3,718,888 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2022-12-31 | 3,926,774 |
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance | 2022-12-31 | 0 |
Reductions in caryover balances due to elections or deemed elections | 2022-12-31 | 0 |
Reductions in prefunding balances due to elections or deemed elections | 2022-12-31 | 0 |
Balance of carryovers at beginning of current year | 2022-12-31 | 0 |
Balance of prefunding at beginning of current year | 2022-12-31 | 3,967 |
Total employer contributions | 2022-12-31 | 2,325,000 |
Total employee contributions | 2022-12-31 | 0 |
Contributions allocated toward unpaid minimum require contributions from prior years | 2022-12-31 | 0 |
Contributions made to avoid restrictions adjusted to valuation date | 2022-12-31 | 0 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2022-12-31 | 2,231,207 |
Unpaid minimum required contributions for all prior years | 2022-12-31 | 0 |
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years | 2022-12-31 | 0 |
Remaining amount of unpaid minimum required contributions | 2022-12-31 | 0 |
Minimum required contributions for current year target normal cost | 2022-12-31 | 780,000 |
Net shortfall amortization installment of oustanding balance | 2022-12-31 | 0 |
Waiver amortization installment | 2022-12-31 | 0 |
Total funding amount beforereflecting carryover/prefunding balances | 2022-12-31 | 0 |
Carryover balance elected to use to offset funding requirement | 2022-12-31 | 0 |
Prefunding balance elected to use to offset funding requirement | 2022-12-31 | 0 |
Additional cash requirement | 2022-12-31 | 0 |
Contributions allocatedtoward minimum required contributions for current year | 2022-12-31 | 2,231,207 |
Unpaid minimum required contributions for current year | 2022-12-31 | 0 |
Unpaid minimum required contributions for all years | 2022-12-31 | 0 |
Total participants, beginning-of-year | 2022-01-01 | 1,714 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 512 |
Number of retired or separated participants receiving benefits | 2022-01-01 | 691 |
Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 415 |
Total of all active and inactive participants | 2022-01-01 | 1,618 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-01-01 | 86 |
Total participants | 2022-01-01 | 1,704 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2022-01-01 | 0 |
2021: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2021 401k membership | ||
Market value of plan assets | 2021-12-31 | 291,006,835 |
Acturial value of plan assets | 2021-12-31 | 261,906,152 |
Funding target for retired participants and beneficiaries receiving payment | 2021-12-31 | 115,290,659 |
Number of terminated vested participants | 2021-12-31 | 449 |
Fundng target for terminated vested participants | 2021-12-31 | 26,028,288 |
Active participant vested funding target | 2021-12-31 | 76,865,119 |
Number of active participants | 2021-12-31 | 581 |
Total funding liabilities for active participants | 2021-12-31 | 77,843,567 |
Total participant count | 2021-12-31 | 1,726 |
Total funding target for all participants | 2021-12-31 | 219,162,514 |
Balance at beginning of prior year after applicable adjustments | 2021-12-31 | 0 |
Prefunding balance at beginning of prior year after applicable adjustments | 2021-12-31 | 3,231 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2021-12-31 | 0 |
Prefunding balanced used to offset prior years funding requirement | 2021-12-31 | 0 |
Amount remaining of carryover balance | 2021-12-31 | 0 |
Amount remaining of prefunding balance | 2021-12-31 | 3,231 |
Present value of excess contributions | 2021-12-31 | 2,995,056 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2021-12-31 | 3,157,089 |
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance | 2021-12-31 | 0 |
Reductions in caryover balances due to elections or deemed elections | 2021-12-31 | 0 |
Reductions in prefunding balances due to elections or deemed elections | 2021-12-31 | 0 |
Balance of carryovers at beginning of current year | 2021-12-31 | 0 |
Balance of prefunding at beginning of current year | 2021-12-31 | 3,746 |
Total employer contributions | 2021-12-31 | 3,875,000 |
Total employee contributions | 2021-12-31 | 0 |
Contributions allocated toward unpaid minimum require contributions from prior years | 2021-12-31 | 0 |
Contributions made to avoid restrictions adjusted to valuation date | 2021-12-31 | 0 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2021-12-31 | 3,718,888 |
Unpaid minimum required contributions for all prior years | 2021-12-31 | 0 |
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years | 2021-12-31 | 0 |
Remaining amount of unpaid minimum required contributions | 2021-12-31 | 0 |
Minimum required contributions for current year target normal cost | 2021-12-31 | 704,000 |
Net shortfall amortization installment of oustanding balance | 2021-12-31 | 0 |
Waiver amortization installment | 2021-12-31 | 0 |
Total funding amount beforereflecting carryover/prefunding balances | 2021-12-31 | 0 |
Carryover balance elected to use to offset funding requirement | 2021-12-31 | 0 |
Prefunding balance elected to use to offset funding requirement | 2021-12-31 | 0 |
Additional cash requirement | 2021-12-31 | 0 |
Contributions allocatedtoward minimum required contributions for current year | 2021-12-31 | 3,718,888 |
Unpaid minimum required contributions for current year | 2021-12-31 | 0 |
Unpaid minimum required contributions for all years | 2021-12-31 | 0 |
Total participants, beginning-of-year | 2021-01-01 | 1,724 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 540 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 665 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 429 |
Total of all active and inactive participants | 2021-01-01 | 1,634 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 80 |
Total participants | 2021-01-01 | 1,714 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 0 |
2020: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2020 401k membership | ||
Market value of plan assets | 2020-12-31 | 257,694,445 |
Acturial value of plan assets | 2020-12-31 | 243,638,812 |
Funding target for retired participants and beneficiaries receiving payment | 2020-12-31 | 108,841,156 |
Number of terminated vested participants | 2020-12-31 | 526 |
Fundng target for terminated vested participants | 2020-12-31 | 28,371,519 |
Active participant vested funding target | 2020-12-31 | 82,975,485 |
Number of active participants | 2020-12-31 | 612 |
Total funding liabilities for active participants | 2020-12-31 | 84,848,303 |
Total participant count | 2020-12-31 | 1,787 |
Total funding target for all participants | 2020-12-31 | 222,060,978 |
Balance at beginning of prior year after applicable adjustments | 2020-12-31 | 0 |
Prefunding balance at beginning of prior year after applicable adjustments | 2020-12-31 | 2,630 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2020-12-31 | 0 |
Prefunding balanced used to offset prior years funding requirement | 2020-12-31 | 0 |
Amount remaining of carryover balance | 2020-12-31 | 0 |
Amount remaining of prefunding balance | 2020-12-31 | 2,630 |
Present value of excess contributions | 2020-12-31 | 18,398,924 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2020-12-31 | 19,423,744 |
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance | 2020-12-31 | 0 |
Reductions in caryover balances due to elections or deemed elections | 2020-12-31 | 0 |
Reductions in prefunding balances due to elections or deemed elections | 2020-12-31 | 0 |
Balance of carryovers at beginning of current year | 2020-12-31 | 0 |
Balance of prefunding at beginning of current year | 2020-12-31 | 3,231 |
Total employer contributions | 2020-12-31 | 3,100,000 |
Total employee contributions | 2020-12-31 | 0 |
Contributions allocated toward unpaid minimum require contributions from prior years | 2020-12-31 | 0 |
Contributions made to avoid restrictions adjusted to valuation date | 2020-12-31 | 0 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2020-12-31 | 2,995,056 |
Liquidity shortfalls end of Q1 | 2020-12-31 | 0 |
Liquidity shortfalls end of Q2 | 2020-12-31 | 0 |
Liquidity shortfalls end of Q3 | 2020-12-31 | 0 |
Liquidity shortfalls end of Q4 | 2020-12-31 | 0 |
Unpaid minimum required contributions for all prior years | 2020-12-31 | 0 |
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years | 2020-12-31 | 0 |
Remaining amount of unpaid minimum required contributions | 2020-12-31 | 0 |
Minimum required contributions for current year target normal cost | 2020-12-31 | 748,000 |
Net shortfall amortization installment of oustanding balance | 2020-12-31 | 0 |
Waiver amortization installment | 2020-12-31 | 0 |
Total funding amount beforereflecting carryover/prefunding balances | 2020-12-31 | 0 |
Additional cash requirement | 2020-12-31 | 0 |
Contributions allocatedtoward minimum required contributions for current year | 2020-12-31 | 2,995,056 |
Unpaid minimum required contributions for current year | 2020-12-31 | 0 |
Unpaid minimum required contributions for all years | 2020-12-31 | 0 |
Total participants, beginning-of-year | 2020-01-01 | 1,785 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 581 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 635 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 432 |
Total of all active and inactive participants | 2020-01-01 | 1,648 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 76 |
Total participants | 2020-01-01 | 1,724 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 0 |
2019: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2019 401k membership | ||
Market value of plan assets | 2019-12-31 | 198,882,716 |
Acturial value of plan assets | 2019-12-31 | 208,270,822 |
Funding target for retired participants and beneficiaries receiving payment | 2019-12-31 | 99,475,411 |
Number of terminated vested participants | 2019-12-31 | 532 |
Fundng target for terminated vested participants | 2019-12-31 | 28,028,142 |
Active participant vested funding target | 2019-12-31 | 83,636,651 |
Number of active participants | 2019-12-31 | 645 |
Total funding liabilities for active participants | 2019-12-31 | 86,133,838 |
Total participant count | 2019-12-31 | 1,800 |
Total funding target for all participants | 2019-12-31 | 213,637,391 |
Balance at beginning of prior year after applicable adjustments | 2019-12-31 | 0 |
Prefunding balance at beginning of prior year after applicable adjustments | 2019-12-31 | 2,817 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2019-12-31 | 0 |
Prefunding balanced used to offset prior years funding requirement | 2019-12-31 | 0 |
Amount remaining of carryover balance | 2019-12-31 | 0 |
Amount remaining of prefunding balance | 2019-12-31 | 2,817 |
Present value of excess contributions | 2019-12-31 | 6,371,304 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2019-12-31 | 6,735,105 |
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance | 2019-12-31 | 0 |
Reductions in caryover balances due to elections or deemed elections | 2019-12-31 | 0 |
Reductions in prefunding balances due to elections or deemed elections | 2019-12-31 | 0 |
Balance of carryovers at beginning of current year | 2019-12-31 | 0 |
Balance of prefunding at beginning of current year | 2019-12-31 | 2,630 |
Total employer contributions | 2019-12-31 | 24,665,292 |
Total employee contributions | 2019-12-31 | 0 |
Contributions allocated toward unpaid minimum require contributions from prior years | 2019-12-31 | 0 |
Contributions made to avoid restrictions adjusted to valuation date | 2019-12-31 | 0 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2019-12-31 | 23,466,966 |
Liquidity shortfalls end of Q1 | 2019-12-31 | 0 |
Liquidity shortfalls end of Q2 | 2019-12-31 | 0 |
Liquidity shortfalls end of Q3 | 2019-12-31 | 0 |
Liquidity shortfalls end of Q4 | 2019-12-31 | 0 |
Unpaid minimum required contributions for all prior years | 2019-12-31 | 0 |
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years | 2019-12-31 | 0 |
Remaining amount of unpaid minimum required contributions | 2019-12-31 | 0 |
Minimum required contributions for current year target normal cost | 2019-12-31 | 2,889,641 |
Net shortfall amortization installment of oustanding balance | 2019-12-31 | 5,369,199 |
Total funding amount beforereflecting carryover/prefunding balances | 2019-12-31 | 5,068,042 |
Carryover balance elected to use to offset funding requirement | 2019-12-31 | 0 |
Prefunding balance elected to use to offset funding requirement | 2019-12-31 | 0 |
Additional cash requirement | 2019-12-31 | 5,068,042 |
Contributions allocatedtoward minimum required contributions for current year | 2019-12-31 | 23,466,966 |
Unpaid minimum required contributions for current year | 2019-12-31 | 0 |
Unpaid minimum required contributions for all years | 2019-12-31 | 0 |
Total participants, beginning-of-year | 2019-01-01 | 1,797 |
Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 612 |
Number of retired or separated participants receiving benefits | 2019-01-01 | 591 |
Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 508 |
Total of all active and inactive participants | 2019-01-01 | 1,711 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-01-01 | 74 |
Total participants | 2019-01-01 | 1,785 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-01-01 | 0 |
2018: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2018 401k membership | ||
Market value of plan assets | 2018-12-31 | 211,370,058 |
Acturial value of plan assets | 2018-12-31 | 197,098,526 |
Funding target for retired participants and beneficiaries receiving payment | 2018-12-31 | 86,135,606 |
Number of terminated vested participants | 2018-12-31 | 539 |
Fundng target for terminated vested participants | 2018-12-31 | 26,403,570 |
Active participant vested funding target | 2018-12-31 | 84,543,206 |
Number of active participants | 2018-12-31 | 689 |
Total funding liabilities for active participants | 2018-12-31 | 87,169,523 |
Total participant count | 2018-12-31 | 1,809 |
Total funding target for all participants | 2018-12-31 | 199,708,699 |
Balance at beginning of prior year after applicable adjustments | 2018-12-31 | 0 |
Prefunding balance at beginning of prior year after applicable adjustments | 2018-12-31 | 0 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2018-12-31 | 0 |
Prefunding balanced used to offset prior years funding requirement | 2018-12-31 | 0 |
Amount remaining of carryover balance | 2018-12-31 | 0 |
Amount remaining of prefunding balance | 2018-12-31 | 0 |
Present value of excess contributions | 2018-12-31 | 2,660 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2018-12-31 | 2,817 |
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance | 2018-12-31 | 2,817 |
Balance of carryovers at beginning of current year | 2018-12-31 | 0 |
Balance of prefunding at beginning of current year | 2018-12-31 | 2,817 |
Total employer contributions | 2018-12-31 | 10,766,374 |
Total employee contributions | 2018-12-31 | 0 |
Contributions allocated toward unpaid minimum require contributions from prior years | 2018-12-31 | 0 |
Contributions made to avoid restrictions adjusted to valuation date | 2018-12-31 | 0 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2018-12-31 | 10,036,597 |
Liquidity shortfalls end of Q1 | 2018-12-31 | 0 |
Liquidity shortfalls end of Q2 | 2018-12-31 | 0 |
Liquidity shortfalls end of Q3 | 2018-12-31 | 0 |
Liquidity shortfalls end of Q4 | 2018-12-31 | 0 |
Unpaid minimum required contributions for all prior years | 2018-12-31 | 0 |
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years | 2018-12-31 | 0 |
Remaining amount of unpaid minimum required contributions | 2018-12-31 | 0 |
Minimum required contributions for current year target normal cost | 2018-12-31 | 3,665,293 |
Net shortfall amortization installment of oustanding balance | 2018-12-31 | 2,612,990 |
Total funding amount beforereflecting carryover/prefunding balances | 2018-12-31 | 3,665,293 |
Additional cash requirement | 2018-12-31 | 3,665,293 |
Contributions allocatedtoward minimum required contributions for current year | 2018-12-31 | 10,036,597 |
Unpaid minimum required contributions for current year | 2018-12-31 | 0 |
Unpaid minimum required contributions for all years | 2018-12-31 | 0 |
Total participants, beginning-of-year | 2018-01-01 | 1,807 |
Total number of active participants reported on line 7a of the Form 5500 | 2018-01-01 | 645 |
Number of retired or separated participants receiving benefits | 2018-01-01 | 561 |
Number of other retired or separated participants entitled to future benefits | 2018-01-01 | 530 |
Total of all active and inactive participants | 2018-01-01 | 1,736 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2018-01-01 | 61 |
Total participants | 2018-01-01 | 1,797 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2018-01-01 | 0 |
2017: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2017 401k membership | ||
Market value of plan assets | 2017-12-31 | 183,754,809 |
Acturial value of plan assets | 2017-12-31 | 187,055,685 |
Funding target for retired participants and beneficiaries receiving payment | 2017-12-31 | 78,705,613 |
Number of terminated vested participants | 2017-12-31 | 547 |
Fundng target for terminated vested participants | 2017-12-31 | 24,919,375 |
Active participant vested funding target | 2017-12-31 | 81,428,076 |
Number of active participants | 2017-12-31 | 719 |
Total funding liabilities for active participants | 2017-12-31 | 85,019,126 |
Total participant count | 2017-12-31 | 1,818 |
Total funding target for all participants | 2017-12-31 | 188,644,114 |
Balance at beginning of prior year after applicable adjustments | 2017-12-31 | 0 |
Prefunding balance at beginning of prior year after applicable adjustments | 2017-12-31 | 0 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2017-12-31 | 0 |
Prefunding balanced used to offset prior years funding requirement | 2017-12-31 | 0 |
Amount remaining of carryover balance | 2017-12-31 | 0 |
Amount remaining of prefunding balance | 2017-12-31 | 0 |
Present value of excess contributions | 2017-12-31 | 3,795,666 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2017-12-31 | 4,027,961 |
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance | 2017-12-31 | 4,027,961 |
Reductions in prefunding balances due to elections or deemed elections | 2017-12-31 | 4,027,961 |
Balance of carryovers at beginning of current year | 2017-12-31 | 0 |
Balance of prefunding at beginning of current year | 2017-12-31 | 0 |
Total employer contributions | 2017-12-31 | 5,810,633 |
Total employee contributions | 2017-12-31 | 0 |
Contributions allocated toward unpaid minimum require contributions from prior years | 2017-12-31 | 0 |
Contributions made to avoid restrictions adjusted to valuation date | 2017-12-31 | 0 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2017-12-31 | 5,619,245 |
Liquidity shortfalls end of Q1 | 2017-12-31 | 0 |
Liquidity shortfalls end of Q2 | 2017-12-31 | 0 |
Liquidity shortfalls end of Q3 | 2017-12-31 | 0 |
Liquidity shortfalls end of Q4 | 2017-12-31 | 0 |
Unpaid minimum required contributions for all prior years | 2017-12-31 | 0 |
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years | 2017-12-31 | 0 |
Remaining amount of unpaid minimum required contributions | 2017-12-31 | 0 |
Minimum required contributions for current year target normal cost | 2017-12-31 | 3,650,652 |
Net shortfall amortization installment of oustanding balance | 2017-12-31 | 1,588,429 |
Total funding amount beforereflecting carryover/prefunding balances | 2017-12-31 | 5,616,585 |
Additional cash requirement | 2017-12-31 | 5,616,585 |
Contributions allocatedtoward minimum required contributions for current year | 2017-12-31 | 5,619,245 |
Unpaid minimum required contributions for current year | 2017-12-31 | 0 |
Unpaid minimum required contributions for all years | 2017-12-31 | 0 |
Total participants, beginning-of-year | 2017-01-01 | 1,816 |
Total number of active participants reported on line 7a of the Form 5500 | 2017-01-01 | 689 |
Number of retired or separated participants receiving benefits | 2017-01-01 | 537 |
Number of other retired or separated participants entitled to future benefits | 2017-01-01 | 522 |
Total of all active and inactive participants | 2017-01-01 | 1,748 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2017-01-01 | 59 |
Total participants | 2017-01-01 | 1,807 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2017-01-01 | 0 |
2016: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2016 401k membership | ||
Market value of plan assets | 2016-12-31 | 168,608,556 |
Acturial value of plan assets | 2016-12-31 | 173,808,957 |
Funding target for retired participants and beneficiaries receiving payment | 2016-12-31 | 66,121,197 |
Number of terminated vested participants | 2016-12-31 | 560 |
Fundng target for terminated vested participants | 2016-12-31 | 25,034,022 |
Active participant vested funding target | 2016-12-31 | 79,775,495 |
Number of active participants | 2016-12-31 | 764 |
Total funding liabilities for active participants | 2016-12-31 | 84,320,941 |
Total participant count | 2016-12-31 | 1,825 |
Total funding target for all participants | 2016-12-31 | 175,476,160 |
Balance at beginning of prior year after applicable adjustments | 2016-12-31 | 0 |
Prefunding balance at beginning of prior year after applicable adjustments | 2016-12-31 | 1,486,959 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2016-12-31 | 0 |
Prefunding balanced used to offset prior years funding requirement | 2016-12-31 | 0 |
Amount remaining of carryover balance | 2016-12-31 | 0 |
Amount remaining of prefunding balance | 2016-12-31 | 1,486,959 |
Present value of excess contributions | 2016-12-31 | 9,294,365 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2016-12-31 | 9,881,769 |
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance | 2016-12-31 | 9,881,769 |
Reductions in prefunding balances due to elections or deemed elections | 2016-12-31 | 11,329,770 |
Balance of carryovers at beginning of current year | 2016-12-31 | 0 |
Balance of prefunding at beginning of current year | 2016-12-31 | 0 |
Total employer contributions | 2016-12-31 | 10,277,202 |
Total employee contributions | 2016-12-31 | 0 |
Contributions allocated toward unpaid minimum require contributions from prior years | 2016-12-31 | 0 |
Contributions made to avoid restrictions adjusted to valuation date | 2016-12-31 | 0 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2016-12-31 | 9,634,502 |
Liquidity shortfalls end of Q1 | 2016-12-31 | 0 |
Liquidity shortfalls end of Q2 | 2016-12-31 | 0 |
Liquidity shortfalls end of Q3 | 2016-12-31 | 0 |
Liquidity shortfalls end of Q4 | 2016-12-31 | 0 |
Unpaid minimum required contributions for all prior years | 2016-12-31 | 0 |
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years | 2016-12-31 | 0 |
Remaining amount of unpaid minimum required contributions | 2016-12-31 | 0 |
Minimum required contributions for current year target normal cost | 2016-12-31 | 4,149,606 |
Net shortfall amortization installment of oustanding balance | 2016-12-31 | 1,667,203 |
Total funding amount beforereflecting carryover/prefunding balances | 2016-12-31 | 5,838,836 |
Additional cash requirement | 2016-12-31 | 5,838,836 |
Contributions allocatedtoward minimum required contributions for current year | 2016-12-31 | 9,634,502 |
Unpaid minimum required contributions for current year | 2016-12-31 | 0 |
Unpaid minimum required contributions for all years | 2016-12-31 | 0 |
Total participants, beginning-of-year | 2016-01-01 | 1,825 |
Total number of active participants reported on line 7a of the Form 5500 | 2016-01-01 | 719 |
Number of retired or separated participants receiving benefits | 2016-01-01 | 495 |
Number of other retired or separated participants entitled to future benefits | 2016-01-01 | 545 |
Total of all active and inactive participants | 2016-01-01 | 1,759 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2016-01-01 | 57 |
Total participants | 2016-01-01 | 1,816 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2016-01-01 | 0 |
2015: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2015 401k membership | ||
Total participants, beginning-of-year | 2015-01-01 | 1,832 |
Total number of active participants reported on line 7a of the Form 5500 | 2015-01-01 | 764 |
Number of retired or separated participants receiving benefits | 2015-01-01 | 447 |
Number of other retired or separated participants entitled to future benefits | 2015-01-01 | 558 |
Total of all active and inactive participants | 2015-01-01 | 1,769 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2015-01-01 | 56 |
Total participants | 2015-01-01 | 1,825 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2015-01-01 | 0 |
2014: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2014 401k membership | ||
Total participants, beginning-of-year | 2014-01-01 | 1,849 |
Total number of active participants reported on line 7a of the Form 5500 | 2014-01-01 | 813 |
Number of retired or separated participants receiving benefits | 2014-01-01 | 420 |
Number of other retired or separated participants entitled to future benefits | 2014-01-01 | 550 |
Total of all active and inactive participants | 2014-01-01 | 1,783 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2014-01-01 | 49 |
Total participants | 2014-01-01 | 1,832 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2014-01-01 | 0 |
2013: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2013 401k membership | ||
Total participants, beginning-of-year | 2013-01-01 | 1,864 |
Total number of active participants reported on line 7a of the Form 5500 | 2013-01-01 | 877 |
Number of retired or separated participants receiving benefits | 2013-01-01 | 379 |
Number of other retired or separated participants entitled to future benefits | 2013-01-01 | 548 |
Total of all active and inactive participants | 2013-01-01 | 1,804 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2013-01-01 | 45 |
Total participants | 2013-01-01 | 1,849 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2013-01-01 | 0 |
2012: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2012 401k membership | ||
Total participants, beginning-of-year | 2012-01-01 | 1,880 |
Total number of active participants reported on line 7a of the Form 5500 | 2012-01-01 | 974 |
Number of retired or separated participants receiving benefits | 2012-01-01 | 342 |
Number of other retired or separated participants entitled to future benefits | 2012-01-01 | 509 |
Total of all active and inactive participants | 2012-01-01 | 1,825 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2012-01-01 | 39 |
Total participants | 2012-01-01 | 1,864 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2012-01-01 | 1 |
2011: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2011 401k membership | ||
Total participants, beginning-of-year | 2011-01-01 | 1,896 |
Total number of active participants reported on line 7a of the Form 5500 | 2011-01-01 | 1,046 |
Number of retired or separated participants receiving benefits | 2011-01-01 | 309 |
Number of other retired or separated participants entitled to future benefits | 2011-01-01 | 491 |
Total of all active and inactive participants | 2011-01-01 | 1,846 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2011-01-01 | 34 |
Total participants | 2011-01-01 | 1,880 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2011-01-01 | 3 |
2009: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2009 401k membership | ||
Total participants, beginning-of-year | 2009-01-01 | 1,914 |
Total number of active participants reported on line 7a of the Form 5500 | 2009-01-01 | 1,220 |
Number of retired or separated participants receiving benefits | 2009-01-01 | 233 |
Number of other retired or separated participants entitled to future benefits | 2009-01-01 | 413 |
Total of all active and inactive participants | 2009-01-01 | 1,866 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2009-01-01 | 30 |
Total participants | 2009-01-01 | 1,896 |
Number of participants with account balances | 2009-01-01 | 0 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2009-01-01 | 14 |
Measure | Date | Value |
---|---|---|
2022 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2022 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
Total transfer of assets to this plan | 2022-12-31 | $725,869 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total income from all sources (including contributions) | 2022-12-31 | $-69,981,577 |
Total loss/gain on sale of assets | 2022-12-31 | $0 |
Total of all expenses incurred | 2022-12-31 | $12,250,216 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $11,660,242 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $2,325,000 |
Value of total assets at end of year | 2022-12-31 | $219,228,229 |
Value of total assets at beginning of year | 2022-12-31 | $300,734,153 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $589,974 |
Total interest from all sources | 2022-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $4,089,539 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $4,089,539 |
Administrative expenses professional fees incurred | 2022-12-31 | $276,541 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $46,408 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $0 |
Administrative expenses (other) incurred | 2022-12-31 | $150,832 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-82,231,793 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $219,228,229 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $300,734,153 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Investment advisory and management fees | 2022-12-31 | $162,601 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $156,339,074 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $209,769,772 |
Value of interest in common/collective trusts at end of year | 2022-12-31 | $59,966,224 |
Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $76,478,985 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $2,101,523 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $12,935,396 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $12,935,396 |
Net investment gain or loss from common/collective trusts | 2022-12-31 | $-76,396,116 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Contributions received in cash from employer | 2022-12-31 | $2,325,000 |
Employer contributions (assets) at end of year | 2022-12-31 | $775,000 |
Employer contributions (assets) at beginning of year | 2022-12-31 | $1,550,000 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $11,660,242 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | APRIO LLP |
Accountancy firm EIN | 2022-12-31 | 571157523 |
2021 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2021 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
Total transfer of assets to this plan | 2021-12-31 | $456,026 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $20,779,722 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $11,615,364 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $10,691,179 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $3,875,000 |
Value of total assets at end of year | 2021-12-31 | $300,734,153 |
Value of total assets at beginning of year | 2021-12-31 | $291,113,769 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $924,185 |
Total interest from all sources | 2021-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $4,042,927 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $4,042,927 |
Administrative expenses professional fees incurred | 2021-12-31 | $510,569 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $105,481 |
Administrative expenses (other) incurred | 2021-12-31 | $148,264 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $9,164,358 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $300,734,153 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $291,113,769 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Investment advisory and management fees | 2021-12-31 | $265,352 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $209,769,772 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $193,242,452 |
Value of interest in common/collective trusts at end of year | 2021-12-31 | $76,478,985 |
Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $76,293,946 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $12,935,396 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $20,696,890 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $20,696,890 |
Net investment gain or loss from common/collective trusts | 2021-12-31 | $12,861,795 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $3,875,000 |
Employer contributions (assets) at end of year | 2021-12-31 | $1,550,000 |
Employer contributions (assets) at beginning of year | 2021-12-31 | $775,000 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $10,691,179 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | ARONSON LLC |
Accountancy firm EIN | 2021-12-31 | 371611326 |
2020 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2020 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total transfer of assets to this plan | 2020-12-31 | $934,474 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $43,323,957 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $10,840,869 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $10,189,601 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $3,100,000 |
Value of total assets at end of year | 2020-12-31 | $291,113,769 |
Value of total assets at beginning of year | 2020-12-31 | $257,696,207 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $651,268 |
Total interest from all sources | 2020-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $4,952,289 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $4,952,289 |
Administrative expenses professional fees incurred | 2020-12-31 | $269,145 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $105,481 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $14,890 |
Administrative expenses (other) incurred | 2020-12-31 | $164,040 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $32,483,088 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $291,113,769 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $257,696,207 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Investment advisory and management fees | 2020-12-31 | $218,083 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $193,242,452 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $163,570,840 |
Value of interest in common/collective trusts at end of year | 2020-12-31 | $76,293,946 |
Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $65,998,904 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $20,696,890 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $27,195,250 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $27,195,250 |
Net investment gain or loss from common/collective trusts | 2020-12-31 | $35,271,668 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $3,100,000 |
Employer contributions (assets) at end of year | 2020-12-31 | $775,000 |
Employer contributions (assets) at beginning of year | 2020-12-31 | $916,323 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $10,189,601 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | ARONSON LLC |
Accountancy firm EIN | 2020-12-31 | 371611326 |
2019 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2019 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total transfer of assets to this plan | 2019-12-31 | $1,124,049 |
Total transfer of assets to this plan | 2019-12-31 | $1,124,049 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total income from all sources (including contributions) | 2019-12-31 | $68,408,249 |
Total income from all sources (including contributions) | 2019-12-31 | $68,408,249 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total of all expenses incurred | 2019-12-31 | $10,984,144 |
Total of all expenses incurred | 2019-12-31 | $10,984,144 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $9,264,153 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $9,264,153 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $24,665,292 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $24,665,292 |
Value of total assets at end of year | 2019-12-31 | $257,696,207 |
Value of total assets at end of year | 2019-12-31 | $257,696,207 |
Value of total assets at beginning of year | 2019-12-31 | $199,148,053 |
Value of total assets at beginning of year | 2019-12-31 | $199,148,053 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $1,719,991 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $1,719,991 |
Total interest from all sources | 2019-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $4,290,424 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $4,290,424 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $4,290,424 |
Administrative expenses professional fees incurred | 2019-12-31 | $410,560 |
Administrative expenses professional fees incurred | 2019-12-31 | $410,560 |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $3,000,000 |
Value of fidelity bond cover | 2019-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2019-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $14,890 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $14,890 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $58,753 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $58,753 |
Administrative expenses (other) incurred | 2019-12-31 | $1,115,937 |
Administrative expenses (other) incurred | 2019-12-31 | $1,115,937 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $57,424,105 |
Value of net income/loss | 2019-12-31 | $57,424,105 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $257,696,207 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $257,696,207 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $199,148,053 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $199,148,053 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Investment advisory and management fees | 2019-12-31 | $193,494 |
Investment advisory and management fees | 2019-12-31 | $193,494 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $163,570,840 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $163,570,840 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $138,914,245 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $138,914,245 |
Value of interest in common/collective trusts at end of year | 2019-12-31 | $65,998,904 |
Value of interest in common/collective trusts at end of year | 2019-12-31 | $65,998,904 |
Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $53,120,720 |
Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $53,120,720 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $27,195,250 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $27,195,250 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $54,335 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $54,335 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $54,335 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $54,335 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $26,467,280 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $26,467,280 |
Net investment gain or loss from common/collective trusts | 2019-12-31 | $12,985,253 |
Net investment gain or loss from common/collective trusts | 2019-12-31 | $12,985,253 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | Yes |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $24,665,292 |
Contributions received in cash from employer | 2019-12-31 | $24,665,292 |
Employer contributions (assets) at end of year | 2019-12-31 | $916,323 |
Employer contributions (assets) at end of year | 2019-12-31 | $916,323 |
Employer contributions (assets) at beginning of year | 2019-12-31 | $7,000,000 |
Employer contributions (assets) at beginning of year | 2019-12-31 | $7,000,000 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $9,264,153 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $9,264,153 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | ARONSON LLC |
Accountancy firm name | 2019-12-31 | ARONSON LLC |
Accountancy firm EIN | 2019-12-31 | 371611326 |
Accountancy firm EIN | 2019-12-31 | 371611326 |
2018 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2018 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2018-12-31 | $0 |
Total transfer of assets to this plan | 2018-12-31 | $888,276 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total income from all sources (including contributions) | 2018-12-31 | $-3,093,249 |
Total loss/gain on sale of assets | 2018-12-31 | $0 |
Total of all expenses incurred | 2018-12-31 | $10,019,326 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $8,369,940 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $10,766,374 |
Value of total assets at end of year | 2018-12-31 | $199,148,053 |
Value of total assets at beginning of year | 2018-12-31 | $211,372,352 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $1,649,386 |
Total interest from all sources | 2018-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $3,696,024 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $3,696,024 |
Administrative expenses professional fees incurred | 2018-12-31 | $340,847 |
Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
Value of fidelity bond cover | 2018-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2018-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2018-12-31 | $58,753 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2018-12-31 | $3,118 |
Other income not declared elsewhere | 2018-12-31 | $0 |
Administrative expenses (other) incurred | 2018-12-31 | $1,078,779 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $-13,112,575 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $199,148,053 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $211,372,352 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Investment advisory and management fees | 2018-12-31 | $229,760 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $138,914,245 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $151,970,113 |
Value of interest in common/collective trusts at end of year | 2018-12-31 | $53,120,720 |
Value of interest in common/collective trusts at beginning of year | 2018-12-31 | $54,106,390 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2018-12-31 | $54,335 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2018-12-31 | $3,835,968 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2018-12-31 | $3,835,968 |
Net investment gain or loss from common/collective trusts | 2018-12-31 | $-3,874,831 |
Net gain/loss from 103.12 investment entities | 2018-12-31 | $-13,680,816 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Contributions received in cash from employer | 2018-12-31 | $10,766,374 |
Employer contributions (assets) at end of year | 2018-12-31 | $7,000,000 |
Employer contributions (assets) at beginning of year | 2018-12-31 | $1,456,763 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $8,369,940 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
Accountancy firm name | 2018-12-31 | ARONSON LLC |
Accountancy firm EIN | 2018-12-31 | 371611326 |
2017 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2017 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2017-12-31 | $0 |
Total transfer of assets to this plan | 2017-12-31 | $674,552 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total income from all sources (including contributions) | 2017-12-31 | $36,039,421 |
Total loss/gain on sale of assets | 2017-12-31 | $0 |
Total of all expenses incurred | 2017-12-31 | $9,295,905 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $7,722,862 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $5,810,633 |
Value of total assets at end of year | 2017-12-31 | $211,372,352 |
Value of total assets at beginning of year | 2017-12-31 | $183,954,284 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $1,573,043 |
Total interest from all sources | 2017-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $3,578,057 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $3,578,057 |
Administrative expenses professional fees incurred | 2017-12-31 | $292,154 |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2017-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2017-12-31 | $0 |
Assets. Other investments not covered elsewhere at beginning of year | 2017-12-31 | $1,782 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2017-12-31 | $3,118 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2017-12-31 | $0 |
Administrative expenses (other) incurred | 2017-12-31 | $1,064,176 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $26,743,516 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $211,372,352 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $183,954,284 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Investment advisory and management fees | 2017-12-31 | $216,713 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $151,970,113 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $123,586,344 |
Value of interest in common/collective trusts at end of year | 2017-12-31 | $54,106,390 |
Value of interest in common/collective trusts at beginning of year | 2017-12-31 | $44,425,414 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2017-12-31 | $3,835,968 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2017-12-31 | $10,883,203 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2017-12-31 | $10,883,203 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $10,360,711 |
Net investment gain or loss from common/collective trusts | 2017-12-31 | $16,290,020 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Contributions received in cash from employer | 2017-12-31 | $5,810,633 |
Employer contributions (assets) at end of year | 2017-12-31 | $1,456,763 |
Employer contributions (assets) at beginning of year | 2017-12-31 | $5,057,541 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $7,722,862 |
Contract administrator fees | 2017-12-31 | $0 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
Accountancy firm name | 2017-12-31 | ARONSON LLC |
Accountancy firm EIN | 2017-12-31 | 371611326 |
2016 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2016 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2016-12-31 | $0 |
Total transfer of assets to this plan | 2016-12-31 | $1,281,685 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total income from all sources (including contributions) | 2016-12-31 | $21,872,602 |
Total loss/gain on sale of assets | 2016-12-31 | $0 |
Total of all expenses incurred | 2016-12-31 | $8,234,843 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $6,781,473 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $10,277,202 |
Value of total assets at end of year | 2016-12-31 | $183,954,284 |
Value of total assets at beginning of year | 2016-12-31 | $169,034,840 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $1,453,370 |
Total interest from all sources | 2016-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $3,630,721 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $3,630,721 |
Administrative expenses professional fees incurred | 2016-12-31 | $222,054 |
Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
Value of fidelity bond cover | 2016-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2016-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2016-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2016-12-31 | $1,782 |
Assets. Other investments not covered elsewhere at beginning of year | 2016-12-31 | $0 |
Administrative expenses (other) incurred | 2016-12-31 | $1,029,300 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Value of net income/loss | 2016-12-31 | $13,637,759 |
Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $183,954,284 |
Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $169,034,840 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
Investment advisory and management fees | 2016-12-31 | $202,016 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $123,586,344 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $113,391,735 |
Value of interest in common/collective trusts at end of year | 2016-12-31 | $44,425,414 |
Value of interest in common/collective trusts at beginning of year | 2016-12-31 | $39,929,228 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2016-12-31 | $10,883,203 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2016-12-31 | $3,815,747 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2016-12-31 | $3,815,747 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $7,964,679 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
Contributions received in cash from employer | 2016-12-31 | $10,277,202 |
Employer contributions (assets) at end of year | 2016-12-31 | $5,057,541 |
Employer contributions (assets) at beginning of year | 2016-12-31 | $11,898,130 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $6,781,473 |
Contract administrator fees | 2016-12-31 | $0 |
Did the plan have assets held for investment | 2016-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Disclaimer |
Accountancy firm name | 2016-12-31 | ARONSON LLC |
Accountancy firm EIN | 2016-12-31 | 371611326 |
2015 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2015 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2015-12-31 | $0 |
Total transfer of assets to this plan | 2015-12-31 | $1,208,234 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total income from all sources (including contributions) | 2015-12-31 | $13,338,327 |
Total loss/gain on sale of assets | 2015-12-31 | $0 |
Total of all expenses incurred | 2015-12-31 | $7,279,234 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $5,889,125 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $17,543,848 |
Value of total assets at end of year | 2015-12-31 | $169,034,840 |
Value of total assets at beginning of year | 2015-12-31 | $161,767,513 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $1,390,109 |
Total interest from all sources | 2015-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $3,176,117 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2015-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2015-12-31 | $3,176,117 |
Administrative expenses professional fees incurred | 2015-12-31 | $325,390 |
Was this plan covered by a fidelity bond | 2015-12-31 | Yes |
Value of fidelity bond cover | 2015-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2015-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2015-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
Other income not declared elsewhere | 2015-12-31 | $0 |
Administrative expenses (other) incurred | 2015-12-31 | $870,200 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Value of net income/loss | 2015-12-31 | $6,059,093 |
Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $169,034,840 |
Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $161,767,513 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2015-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
Investment advisory and management fees | 2015-12-31 | $194,519 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $113,391,735 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $116,013,175 |
Value of interest in common/collective trusts at end of year | 2015-12-31 | $39,929,228 |
Value of interest in common/collective trusts at beginning of year | 2015-12-31 | $41,625,842 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2015-12-31 | $3,815,747 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2015-12-31 | $1,509,457 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2015-12-31 | $1,509,457 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-7,381,638 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2015-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2015-12-31 | No |
Contributions received in cash from employer | 2015-12-31 | $17,543,848 |
Employer contributions (assets) at end of year | 2015-12-31 | $11,898,130 |
Employer contributions (assets) at beginning of year | 2015-12-31 | $2,619,039 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2015-12-31 | $5,889,125 |
Contract administrator fees | 2015-12-31 | $0 |
Did the plan have assets held for investment | 2015-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2015-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2015-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2015-12-31 | Disclaimer |
Accountancy firm name | 2015-12-31 | ARONSON LLC |
Accountancy firm EIN | 2015-12-31 | 371611326 |
2014 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2014 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2014-12-31 | $0 |
Total transfer of assets to this plan | 2014-12-31 | $1,444,866 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total income from all sources (including contributions) | 2014-12-31 | $28,934,091 |
Total loss/gain on sale of assets | 2014-12-31 | $0 |
Total of all expenses incurred | 2014-12-31 | $6,274,747 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $5,086,601 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $7,724,091 |
Value of total assets at end of year | 2014-12-31 | $161,767,513 |
Value of total assets at beginning of year | 2014-12-31 | $137,663,303 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $1,188,146 |
Total interest from all sources | 2014-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $2,961,035 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2014-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2014-12-31 | $2,961,035 |
Administrative expenses professional fees incurred | 2014-12-31 | $457,477 |
Was this plan covered by a fidelity bond | 2014-12-31 | Yes |
Value of fidelity bond cover | 2014-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2014-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2014-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
Other income not declared elsewhere | 2014-12-31 | $0 |
Administrative expenses (other) incurred | 2014-12-31 | $584,787 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Value of net income/loss | 2014-12-31 | $22,659,344 |
Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $161,767,513 |
Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $137,663,303 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2014-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
Investment advisory and management fees | 2014-12-31 | $145,882 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2014-12-31 | $116,013,175 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2014-12-31 | $95,417,824 |
Value of interest in common/collective trusts at end of year | 2014-12-31 | $41,625,842 |
Value of interest in common/collective trusts at beginning of year | 2014-12-31 | $35,714,438 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2014-12-31 | $1,509,457 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2014-12-31 | $1,089,687 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2014-12-31 | $1,089,687 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2014-12-31 | $18,248,965 |
Net investment gain or loss from common/collective trusts | 2014-12-31 | $0 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2014-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2014-12-31 | No |
Contributions received in cash from employer | 2014-12-31 | $7,724,091 |
Employer contributions (assets) at end of year | 2014-12-31 | $2,619,039 |
Employer contributions (assets) at beginning of year | 2014-12-31 | $5,441,354 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2014-12-31 | $5,086,601 |
Did the plan have assets held for investment | 2014-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2014-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2014-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2014-12-31 | Disclaimer |
Accountancy firm name | 2014-12-31 | ARONSON LLC |
Accountancy firm EIN | 2014-12-31 | 371611326 |
2013 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2013 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2013-12-31 | $0 |
Total transfer of assets to this plan | 2013-12-31 | $1,953,063 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total income from all sources (including contributions) | 2013-12-31 | $16,359,393 |
Total loss/gain on sale of assets | 2013-12-31 | $0 |
Total of all expenses incurred | 2013-12-31 | $5,231,965 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $4,413,733 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $10,434,416 |
Value of total assets at end of year | 2013-12-31 | $137,663,303 |
Value of total assets at beginning of year | 2013-12-31 | $124,582,812 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $818,232 |
Total interest from all sources | 2013-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $2,637,240 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2013-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2013-12-31 | $2,637,240 |
Administrative expenses professional fees incurred | 2013-12-31 | $309,538 |
Was this plan covered by a fidelity bond | 2013-12-31 | Yes |
Value of fidelity bond cover | 2013-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2013-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2013-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2013-12-31 | $10,898 |
Other income not declared elsewhere | 2013-12-31 | $111 |
Administrative expenses (other) incurred | 2013-12-31 | $376,170 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Value of net income/loss | 2013-12-31 | $11,127,428 |
Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $137,663,303 |
Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $124,582,812 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2013-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
Investment advisory and management fees | 2013-12-31 | $132,524 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2013-12-31 | $95,417,824 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2013-12-31 | $90,017,712 |
Value of interest in common/collective trusts at end of year | 2013-12-31 | $35,714,438 |
Value of interest in common/collective trusts at beginning of year | 2013-12-31 | $33,581,072 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2013-12-31 | $1,089,687 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2013-12-31 | $973,130 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2013-12-31 | $973,130 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2013-12-31 | $5,062,821 |
Net investment gain or loss from common/collective trusts | 2013-12-31 | $-1,775,195 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2013-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2013-12-31 | No |
Contributions received in cash from employer | 2013-12-31 | $10,434,416 |
Employer contributions (assets) at end of year | 2013-12-31 | $5,441,354 |
Employer contributions (assets) at beginning of year | 2013-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2013-12-31 | $4,413,733 |
Did the plan have assets held for investment | 2013-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2013-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2013-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2013-12-31 | Disclaimer |
Accountancy firm name | 2013-12-31 | ARONSON LLC |
Accountancy firm EIN | 2013-12-31 | 371611326 |
2012 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2012 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2012-12-31 | $0 |
Total transfer of assets to this plan | 2012-12-31 | $1,844,346 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total income from all sources (including contributions) | 2012-12-31 | $20,038,715 |
Total loss/gain on sale of assets | 2012-12-31 | $0 |
Total of all expenses incurred | 2012-12-31 | $4,615,859 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $3,826,882 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $6,815,406 |
Value of total assets at end of year | 2012-12-31 | $124,582,812 |
Value of total assets at beginning of year | 2012-12-31 | $107,315,610 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-12-31 | $788,977 |
Total interest from all sources | 2012-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $3,054,273 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2012-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2012-12-31 | $3,054,273 |
Administrative expenses professional fees incurred | 2012-12-31 | $441,744 |
Was this plan covered by a fidelity bond | 2012-12-31 | Yes |
Value of fidelity bond cover | 2012-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2012-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2012-12-31 | Yes |
Amount of non-exempt transactions with any party-in-interest | 2012-12-31 | $10,577 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2012-12-31 | $10,898 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2012-12-31 | $285,161 |
Administrative expenses (other) incurred | 2012-12-31 | $256,321 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Value of net income/loss | 2012-12-31 | $15,422,856 |
Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $124,582,812 |
Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $107,315,610 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2012-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2012-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2012-12-31 | No |
Investment advisory and management fees | 2012-12-31 | $90,912 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2012-12-31 | $90,017,712 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2012-12-31 | $102,762,859 |
Value of interest in common/collective trusts at end of year | 2012-12-31 | $33,581,072 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2012-12-31 | $973,130 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2012-12-31 | $-24,317 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2012-12-31 | $-24,317 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2012-12-31 | $10,169,036 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2012-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2012-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2012-12-31 | No |
Contributions received in cash from employer | 2012-12-31 | $6,815,406 |
Employer contributions (assets) at end of year | 2012-12-31 | $0 |
Employer contributions (assets) at beginning of year | 2012-12-31 | $4,291,907 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2012-12-31 | $3,826,882 |
Did the plan have assets held for investment | 2012-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2012-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2012-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2012-12-31 | Disclaimer |
Accountancy firm name | 2012-12-31 | ARONSON LLC |
Accountancy firm EIN | 2012-12-31 | 371611326 |
2011 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2011 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2011-12-31 | $0 |
Total transfer of assets to this plan | 2011-12-31 | $505,744 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total income from all sources (including contributions) | 2011-12-31 | $13,568,900 |
Total loss/gain on sale of assets | 2011-12-31 | $0 |
Total of all expenses incurred | 2011-12-31 | $3,354,733 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $2,807,466 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $12,005,486 |
Value of total assets at end of year | 2011-12-31 | $107,315,610 |
Value of total assets at beginning of year | 2011-12-31 | $96,595,699 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $547,267 |
Total interest from all sources | 2011-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2011-12-31 | No |
Administrative expenses professional fees incurred | 2011-12-31 | $368,150 |
Was this plan covered by a fidelity bond | 2011-12-31 | Yes |
Value of fidelity bond cover | 2011-12-31 | $3,000,000 |
If this is an individual account plan, was there a blackout period | 2011-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2011-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2011-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2011-12-31 | $285,161 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2011-12-31 | $0 |
Administrative expenses (other) incurred | 2011-12-31 | $128,496 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Value of net income/loss | 2011-12-31 | $10,214,167 |
Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $107,315,610 |
Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $96,595,699 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2011-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2011-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2011-12-31 | No |
Investment advisory and management fees | 2011-12-31 | $50,621 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2011-12-31 | $102,762,859 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2011-12-31 | $94,297,624 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2011-12-31 | $-24,317 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2011-12-31 | $198,211 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2011-12-31 | $198,211 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2011-12-31 | $1,563,414 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2011-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2011-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2011-12-31 | No |
Contributions received in cash from employer | 2011-12-31 | $12,005,486 |
Employer contributions (assets) at end of year | 2011-12-31 | $4,291,907 |
Employer contributions (assets) at beginning of year | 2011-12-31 | $2,099,864 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2011-12-31 | $2,807,466 |
Did the plan have assets held for investment | 2011-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2011-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2011-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2011-12-31 | Disclaimer |
Accountancy firm name | 2011-12-31 | ARONSON LLC |
Accountancy firm EIN | 2011-12-31 | 371611326 |
2010 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2010 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2010-12-31 | $0 |
Total transfer of assets to this plan | 2010-12-31 | $117,687 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
Total income from all sources (including contributions) | 2010-12-31 | $19,095,992 |
Total loss/gain on sale of assets | 2010-12-31 | $0 |
Total of all expenses incurred | 2010-12-31 | $2,698,482 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2010-12-31 | $2,229,885 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2010-12-31 | $10,009,183 |
Value of total assets at end of year | 2010-12-31 | $96,595,699 |
Value of total assets at beginning of year | 2010-12-31 | $80,080,502 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-12-31 | $468,597 |
Total interest from all sources | 2010-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2010-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2010-12-31 | No |
Administrative expenses professional fees incurred | 2010-12-31 | $331,043 |
Was this plan covered by a fidelity bond | 2010-12-31 | Yes |
Value of fidelity bond cover | 2010-12-31 | $1,000,000 |
If this is an individual account plan, was there a blackout period | 2010-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2010-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2010-12-31 | Yes |
Amount of non-exempt transactions with any party-in-interest | 2010-12-31 | $13,692 |
Income. Received or receivable in cash from other sources (including rollovers) | 2010-12-31 | $662 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2010-12-31 | $0 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2010-12-31 | $168,562 |
Administrative expenses (other) incurred | 2010-12-31 | $109,416 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Value of net income/loss | 2010-12-31 | $16,397,510 |
Value of net assets at end of year (total assets less liabilities) | 2010-12-31 | $96,595,699 |
Value of net assets at beginning of year (total assets less liabilities) | 2010-12-31 | $80,080,502 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2010-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2010-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2010-12-31 | No |
Investment advisory and management fees | 2010-12-31 | $28,138 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2010-12-31 | $94,297,624 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2010-12-31 | $76,400,044 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2010-12-31 | $198,211 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2010-12-31 | $9,086,809 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2010-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2010-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2010-12-31 | No |
Contributions received in cash from employer | 2010-12-31 | $10,008,521 |
Employer contributions (assets) at end of year | 2010-12-31 | $2,099,864 |
Employer contributions (assets) at beginning of year | 2010-12-31 | $3,511,896 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2010-12-31 | $2,229,885 |
Contract administrator fees | 2010-12-31 | $0 |
Did the plan have assets held for investment | 2010-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2010-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2010-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2010-12-31 | Disclaimer |
Accountancy firm name | 2010-12-31 | ARONSON LLC |
Accountancy firm EIN | 2010-12-31 | 371611326 |
2009 : LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2009 401k financial data | ||
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2009-12-31 | $0 |
2022: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2022 form 5500 responses | ||
---|---|---|
2022-01-01 | Type of plan entity | Single employer plan |
2022-01-01 | Submission has been amended | No |
2022-01-01 | This submission is the final filing | No |
2022-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2022-01-01 | Plan is a collectively bargained plan | No |
2022-01-01 | Plan funding arrangement – Trust | Yes |
2022-01-01 | Plan benefit arrangement - Trust | Yes |
2021: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2021 form 5500 responses | ||
2021-01-01 | Type of plan entity | Single employer plan |
2021-01-01 | Submission has been amended | No |
2021-01-01 | This submission is the final filing | No |
2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2021-01-01 | Plan is a collectively bargained plan | No |
2021-01-01 | Plan funding arrangement – Trust | Yes |
2021-01-01 | Plan benefit arrangement - Trust | Yes |
2020: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2020 form 5500 responses | ||
2020-01-01 | Type of plan entity | Single employer plan |
2020-01-01 | Submission has been amended | No |
2020-01-01 | This submission is the final filing | No |
2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2020-01-01 | Plan is a collectively bargained plan | No |
2020-01-01 | Plan funding arrangement – Trust | Yes |
2020-01-01 | Plan benefit arrangement - Trust | Yes |
2019: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2019 form 5500 responses | ||
2019-01-01 | Type of plan entity | Single employer plan |
2019-01-01 | Submission has been amended | No |
2019-01-01 | This submission is the final filing | No |
2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2019-01-01 | Plan is a collectively bargained plan | No |
2019-01-01 | Plan funding arrangement – Trust | Yes |
2019-01-01 | Plan benefit arrangement - Trust | Yes |
2018: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2018 form 5500 responses | ||
2018-01-01 | Type of plan entity | Single employer plan |
2018-01-01 | Submission has been amended | No |
2018-01-01 | This submission is the final filing | No |
2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2018-01-01 | Plan is a collectively bargained plan | No |
2018-01-01 | Plan funding arrangement – Trust | Yes |
2018-01-01 | Plan benefit arrangement - Trust | Yes |
2017: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2017 form 5500 responses | ||
2017-01-01 | Type of plan entity | Single employer plan |
2017-01-01 | Submission has been amended | No |
2017-01-01 | This submission is the final filing | No |
2017-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2017-01-01 | Plan is a collectively bargained plan | No |
2017-01-01 | Plan funding arrangement – Trust | Yes |
2017-01-01 | Plan benefit arrangement - Trust | Yes |
2016: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2016 form 5500 responses | ||
2016-01-01 | Type of plan entity | Single employer plan |
2016-01-01 | Submission has been amended | No |
2016-01-01 | This submission is the final filing | No |
2016-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2016-01-01 | Plan is a collectively bargained plan | No |
2016-01-01 | Plan funding arrangement – Trust | Yes |
2016-01-01 | Plan benefit arrangement - Trust | Yes |
2015: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2015 form 5500 responses | ||
2015-01-01 | Type of plan entity | Single employer plan |
2015-01-01 | Submission has been amended | No |
2015-01-01 | This submission is the final filing | No |
2015-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2015-01-01 | Plan is a collectively bargained plan | No |
2015-01-01 | Plan funding arrangement – Trust | Yes |
2015-01-01 | Plan benefit arrangement - Trust | Yes |
2014: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2014 form 5500 responses | ||
2014-01-01 | Type of plan entity | Single employer plan |
2014-01-01 | Submission has been amended | No |
2014-01-01 | This submission is the final filing | No |
2014-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2014-01-01 | Plan is a collectively bargained plan | No |
2014-01-01 | Plan funding arrangement – Trust | Yes |
2014-01-01 | Plan benefit arrangement - Trust | Yes |
2013: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2013 form 5500 responses | ||
2013-01-01 | Type of plan entity | Single employer plan |
2013-01-01 | Submission has been amended | No |
2013-01-01 | This submission is the final filing | No |
2013-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2013-01-01 | Plan is a collectively bargained plan | No |
2013-01-01 | Plan funding arrangement – Trust | Yes |
2013-01-01 | Plan benefit arrangement - Trust | Yes |
2012: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2012 form 5500 responses | ||
2012-01-01 | Type of plan entity | Single employer plan |
2012-01-01 | Submission has been amended | No |
2012-01-01 | This submission is the final filing | No |
2012-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2012-01-01 | Plan is a collectively bargained plan | No |
2012-01-01 | Plan funding arrangement – Trust | Yes |
2012-01-01 | Plan benefit arrangement - Trust | Yes |
2011: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2011 form 5500 responses | ||
2011-01-01 | Type of plan entity | Single employer plan |
2011-01-01 | Submission has been amended | No |
2011-01-01 | This submission is the final filing | No |
2011-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2011-01-01 | Plan is a collectively bargained plan | No |
2011-01-01 | Plan funding arrangement – Trust | Yes |
2011-01-01 | Plan benefit arrangement - Trust | Yes |
2009: LEIDOS BIOMEDICAL RESEARCH, INC. RETIREMENT PLAN 2009 form 5500 responses | ||
2009-01-01 | Type of plan entity | Single employer plan |
2009-01-01 | Submission has been amended | No |
2009-01-01 | This submission is the final filing | No |
2009-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2009-01-01 | Plan is a collectively bargained plan | No |
2009-01-01 | Plan funding arrangement – Trust | Yes |
2009-01-01 | Plan benefit arrangement - Trust | Yes |